Cancer Series Ep. 4: Cancer is Gone, What Happens Next?

We are in the middle of a series of discussions related to cancer care, treatment improvements, data management in oncology, and the promise of AI to find the right treatment for the right patient in the fastest possible manner. As mentioned by Xose M. Fernandez, a genomicist and former chief data officer at Institute Curie, a faster diagnosis could lead to less aggressive treatment and better patient outcomes. 

We covered many perspectives so far: accessibility and cost of cancer treatments in the US and Canada in the first episode, genetics, data management, and the science of cancer; we talked about AI treatments and challenges in designing clinical trials in personalized medicine.

This episode focuses on the consequences cancer diagnosis has after patients are cured. Many cancer survivors in long-term remission face restricted access to financial services because of their medical history. Some EU countries have already implemented the right to be forgotten – a right for patients not to disclose their medical history. Changes across Europe are happening slowly and given the rising incidence of cancer on the one hand, and scientific advances on the other, we need improvement in the quality of life of patients after they are cured.

In this episode, you will hear from dr. Francoise Meunier,  dr. Francoise Meunier,  member of the Belgian Royal Academy of Medicine, former Director General of European Organisation for Research and Treatment of Cancer, and a Scientific Member of the European Cancer Patient Coalition.

Subscribe to the newsletter to receive a recap of the whole cancer series:

Leave a rating or review:



Registered Users

Please login or register to continue.